在患有脑瘤的患者中药理治疗抑郁症
Johannes Knabbe1, Thomas Kowalski2, Corinna Seliger2
1Department of Psychiatry and Psychotherapy, University Hospital Heidelberg, Heidelberg, Germany.
International journal of cancer
|June 29, 2024
概括
抑郁症在脑瘤患者中很常见,但缺乏治疗指南. 建议服用抗抑郁药,需要进一步的试验来确认其在这个人群中的有效性和安全性.
科学领域:
- 神经瘤学神经瘤学
- 精神病学是一个精神病学.
- 临床药理学 临床药理学
背景情况:
- 患有脑瘤的患者经常经历显著的社会心理困扰,包括高比例的抑郁症状.
- 对脑瘤患者的药理抗抑郁药治疗尚未明确,临床试验数据有限.
研究的目的:
- 审查目前的证据和临床指南,以治疗脑瘤患者的抑郁症.
- 讨论抗抑郁药在这个人群中的副作用,药物相互作用,诊断,查,危险因素和潜在的抗瘤作用.
主要方法:
- 对现有证据和临床指南的文献综述.
- 对脑瘤患者特有的副作用,药物相互作用和风险因素的分析.
- 探索抗抑郁药的潜在抗瘤性质和正在进行的研究.
主要成果:
- 提出了诊断,查和脑瘤患者抑郁症的危险因素的证据.
- 具体的副作用和抗抑郁药的相互作用与这个患者群相关的详细说明.
- 讨论了抗抑郁药的潜在抗瘤作用和相关正在进行的临床试验.
结论:
- 抗抑郁药物不应该被拒绝给被诊断为脑瘤的患者.
- 未来的临床试验对于严格评估抗抑郁药在脑瘤患者中的有效性和安全性至关重要.
相关概念视频
01:23Antidepressant Drugs: MAOIs and Other Agents
215
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
215
01:25Antidepressant Drugs: Overview
433
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
433
01:14Brain Imaging
225
Brain imaging technologies provide critical insights into both the structure and function of the human brain, enabling medical professionals and researchers to diagnose, study, and treat neurological disorders or psychiatric disorders more effectively.
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans), magnetic resonance imaging (MRI), functional magnetic resonance imaging (fMRI), and Transcranial Magnetic...
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans), magnetic resonance imaging (MRI), functional magnetic resonance imaging (fMRI), and Transcranial Magnetic...
225
01:30Electroconvulsive Therapy
31
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
31
01:28Drug Therapy
41
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
41
01:28Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
363
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
363